Shuttle Pharmaceuticals Holdings Inc (SHPH) Stock Price, Quote & News

Company Profile

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HD...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 240 403 4212

Website: www.shuttlepharma.com

Address:

401 Professional Drive, Suite 260, Gaithersburg, United States

JDRebel May. 21 at 5:53 PM

$CLSK $ABTC $DTCX $SHPH them Dogecoin and litecoin miners!!! Doge and litecoin use the same mining rigs! Miners get two for one vs Bitcoin!!! $DOGE.X

0 · Reply

Maxandbear May. 19 at 9:25 PM

$SHPH it is bear

0 · Reply

Maxandbear May. 19 at 9:25 PM

$SHPH why neutral????

0 · Reply

Maxandbear May. 19 at 9:25 PM

$SHPH no press releases nothing. Caution

0 · Reply

Maxandbear May. 19 at 9:24 PM

$SHPH why is there nobody on this page i had the stock 2 days and I am down 58 percent. Careful with this stoclk

0 · Reply

FinacialSuicide May. 15 at 11:07 PM

$SHPH two green days!!

0 · Reply

topstockalerts May. 14 at 8:31 PM

$SHPH the action is getting progressively better.

1 · Reply

FinacialSuicide May. 14 at 8:09 PM

$SHPH Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

0 · Reply

AlertsAndNews May. 14 at 8:07 PM

$SHPH headline here Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

0 · Reply

newsfile_corp May. 14 at 8:06 PM

https://nfne.ws/297554 $SHPH @shuttlepharma #Chemicals #Pharmaceutical #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

May 7, 2026, 2:02 PM EDT - 15 days ago

E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

May 1, 2026, 8:41 AM EDT - 21 days ago

United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation

Apr 30, 2026, 4:05 PM EDT - 22 days ago

Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner

Mar 27, 2026, 8:00 AM EDT - 2 months ago

RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Mar 26, 2026, 4:05 PM EDT - 2 months ago

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Mar 12, 2026, 8:30 AM EDT - 2 months ago

E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals' $3.5 Million Public Offering

Mar 6, 2026, 8:00 AM EST - 2 months ago

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

Jan 13, 2026, 4:00 PM EST - 4 months ago

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever

Nov 21, 2025, 9:30 AM EST - 6 months ago

Shuttle Pharmaceuticals Acquires AI Health Platform

Nov 3, 2025, 7:00 AM EST - 7 months ago

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

Oct 22, 2025, 10:00 AM EDT - 7 months ago

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

Oct 22, 2025, 7:00 AM EDT - 7 months ago

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

Oct 21, 2025, 5:55 PM EDT - 7 months ago

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

Oct 21, 2025, 4:05 PM EDT - 7 months ago

Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform

Oct 10, 2025, 10:20 AM EDT - 8 months ago

Shuttle Executes LOI with Molecule.ai

Oct 9, 2025, 4:15 PM EDT - 8 months ago

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

Aug 14, 2025, 4:05 PM EDT - 10 months ago

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

Jun 24, 2025, 4:10 PM EDT - 11 months ago

Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Jun 20, 2025, 3:55 PM EDT - 1 year ago

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

Jun 12, 2025, 12:00 PM EDT - 1 year ago

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

Jun 12, 2025, 8:30 AM EDT - 1 year ago

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

Jun 4, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

May 15, 2025, 4:45 PM EDT - 1 year ago

Shuttle Pharma Provides Corporate Update

May 8, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

Apr 21, 2025, 4:15 PM EDT - 1 year ago

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Apr 10, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Mar 13, 2025, 4:10 PM EDT - 1 year ago

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

Mar 12, 2025, 9:24 AM EDT - 1 year ago

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

Mar 12, 2025, 6:20 AM EDT - 1 year ago

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Feb 26, 2025, 10:45 AM EST - 1 year ago

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

Jan 7, 2025, 9:00 AM EST - 1 year ago

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Nov 26, 2024, 9:00 AM EST - 1 year ago

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Nov 13, 2024, 5:00 PM EST - 1 year ago

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

Oct 29, 2024, 9:05 PM EDT - 1 year ago

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Oct 28, 2024, 4:05 PM EDT - 1 year ago

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Sep 16, 2024, 9:00 AM EDT - 1 year ago

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Sep 4, 2024, 4:15 PM EDT - 1 year ago

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

Aug 26, 2024, 4:10 PM EDT - 1 year ago

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Aug 14, 2024, 4:10 PM EDT - 1 year ago

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Jul 19, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

Jun 18, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

May 22, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 14, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Provides First Quarter 2024 Corporate Update

Apr 23, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Apr 3, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Mar 22, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

Mar 5, 2024, 9:00 AM EST - 2 years ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024

Feb 13, 2024, 8:00 AM EST - 2 years ago

Shuttle Pharma Announces Its Intent to Pursue a Rights Offering

Jan 23, 2024, 4:30 PM EST - 2 years ago

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

JDRebel May. 21 at 5:53 PM

$CLSK $ABTC $DTCX $SHPH them Dogecoin and litecoin miners!!! Doge and litecoin use the same mining rigs! Miners get two for one vs Bitcoin!!! $DOGE.X

0 · Reply

Maxandbear May. 19 at 9:25 PM

$SHPH it is bear

0 · Reply

Maxandbear May. 19 at 9:25 PM

$SHPH why neutral????

0 · Reply

Maxandbear May. 19 at 9:25 PM

$SHPH no press releases nothing. Caution

0 · Reply

Maxandbear May. 19 at 9:24 PM

$SHPH why is there nobody on this page i had the stock 2 days and I am down 58 percent. Careful with this stoclk

0 · Reply

FinacialSuicide May. 15 at 11:07 PM

$SHPH two green days!!

0 · Reply

topstockalerts May. 14 at 8:31 PM

$SHPH the action is getting progressively better.

1 · Reply

FinacialSuicide May. 14 at 8:09 PM

$SHPH Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

0 · Reply

AlertsAndNews May. 14 at 8:07 PM

$SHPH headline here Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

0 · Reply

newsfile_corp May. 14 at 8:06 PM

https://nfne.ws/297554 $SHPH @shuttlepharma #Chemicals #Pharmaceutical #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

Kanate123 May. 13 at 5:24 PM

$SHPH you have to own codexis beofre a buyout symbol:cdxs

0 · Reply

FinacialSuicide May. 13 at 3:25 PM

$SHPH let’s keep it green!

0 · Reply

MorenitaScorp May. 12 at 1:28 PM

$SHPH ⌚️

0 · Reply

Marko1984 May. 8 at 7:19 PM

$SHPH why does this Keep falling!?

2 · Reply

focafoca99 May. 7 at 9:52 PM

$SHPH merged with United Dogecoin Inc., completing its acquisition and becoming a wholly owned subsidiary of the acquirer.

0 · Reply

CantAffordMe May. 7 at 2:52 PM

$SHPH in the toilet it belongs

0 · Reply

CantAffordMe May. 7 at 2:15 PM

$SHPH Flush thus terd

0 · Reply

321rip May. 6 at 12:50 PM

$SHPH check out $SMX, yest. ended selling

0 · Reply

CantAffordMe May. 6 at 11:22 AM

$SHPH this terd about to blast out the ass

0 · Reply

Stocksgoogle May. 6 at 10:24 AM

$SHPH patience is the key for some of the tickers , this explodes 2-4 times in a year and depending on the entry point, you can make a whole lot, timing the entry at right point is the key and not many have mastered that so key is take profit whenever you can or know when to cut loss short, leave it to you all intelligent people out there. DYOR GLTA

0 · Reply

j_joss420 May. 6 at 12:24 AM

$SHPH MMMMM OK!!

0 · Reply

FinacialSuicide May. 5 at 11:10 PM

$SHPH this is ripped by shorts! Might continue to bleed short term but has a positive future ahead !

0 · Reply

Market Cap	3.47M
Revenue (ttm)	0.00
Net Income (ttm)	-11.72M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	220,900
Avg Vol	1,088,772
Day's Range	N/A - N/A
Shares Out	5.85M
Stochastic %K	35%
Beta	0.38
Analysts	Strong Buy
Price Target	N/A